Skip Nav Destination
Issues
1 June 1983
ISSN 0022-1767
EISSN 1550-6606
In this Issue
COMMUNICATIONS
Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy.
J Immunol (1983) 130 (6): 2496–2498.
Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis.
J Immunol (1983) 130 (6): 2499–2501.
Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
J Immunol (1983) 130 (6): 2505–2507.
Induction of cytotoxic T cell function requires sequential action of three different lymphokines.
J Immunol (1983) 130 (6): 2508–2510.
Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action.
J Immunol (1983) 130 (6): 2511–2513.
ARTICLES
The products of transferred H-2 genes express determinants that restrict hapten-specific cytotoxic T cells.
J Immunol (1983) 130 (6): 2514–2518.
Hapten-specific responses to the phenyltrimethylamino hapten. IV. Occurrence of mechanistically distinct idiotypic suppressor T cells before the appearance of anti-idiotypic suppressor T cells induced by the monovalent antigen L-tyrosine-p-azophenyltrimethylammonium.
J Immunol (1983) 130 (6): 2519–2524.
Ontogeny of con A and PHA responses of chicken blood cells in MHC-compatible lines 6(3) and 7(2).
J Immunol (1983) 130 (6): 2528–2533.
Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
J Immunol (1983) 130 (6): 2534–2541.
Proliferating and helper T lymphocytes display distinct fine specificities in response to human fibrinopeptide B.
J Immunol (1983) 130 (6): 2542–2545.
Cell cycle-dependent expression of antigen-binding and I-J-bearing molecules on suppressor T cell hybridomas.
J Immunol (1983) 130 (6): 2552–2556.
Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
J Immunol (1983) 130 (6): 2557–2560.
Interruption of tolerance toward a haptenic initiator of delayed-type hypersensitivity.
J Immunol (1983) 130 (6): 2561–2564.
Contribution of Lyb 5+ and Lyb 5- B cells to the primary and secondary phosphocholine-specific antibody response.
J Immunol (1983) 130 (6): 2574–2579.
Derivatized guanine nucleosides: a new class of adjuvant for in vitro antibody responses.
J Immunol (1983) 130 (6): 2580–2585.
Seasonal rhythmicity in lymphocyte blastogenic responses of mice persists in a constant environment.
J Immunol (1983) 130 (6): 2586–2588.
Effect of rat alveolar lining material on macrophage receptors.
J Immunol (1983) 130 (6): 2589–2596.
The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man.
J Immunol (1983) 130 (6): 2597–2604.
Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression.
J Immunol (1983) 130 (6): 2623–2628.
Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
J Immunol (1983) 130 (6): 2629–2634.
Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
J Immunol (1983) 130 (6): 2635–2643.
Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
N Flomenberg; K Welte; R Mertelsmann; N Kernan; N Ciobanu; S Venuta; S Feldman; G Kruger; D Kirkpatrick; B Dupont; R O'Reilly
J Immunol (1983) 130 (6): 2644–2650.
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).
J Immunol (1983) 130 (6): 2651–2655.
The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
J Immunol (1983) 130 (6): 2656–2662.
High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
J Immunol (1983) 130 (6): 2663–2665.
Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
J Immunol (1983) 130 (6): 2666–2670.
Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
J Immunol (1983) 130 (6): 2702–2707.
Dependency of human T lymphocyte colony formation on soluble factors produced by accessory or tumor cells.
J Immunol (1983) 130 (6): 2715–2719.
Suppressor cell induction factor: a new mediator released by stimulated human lymphocytes and distinct from previously described lymphokines.
J Immunol (1983) 130 (6): 2720–2726.
Production of a human T lymphocyte chemotactic factor by T cell subpopulations.
J Immunol (1983) 130 (6): 2727–2731.
T cell lines and variant subclones with differing susceptibility to tumor promoters.
J Immunol (1983) 130 (6): 2732–2736.
Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
J Immunol (1983) 130 (6): 2737–2742.
Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse.
J Immunol (1983) 130 (6): 2743–2749.
The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
J Immunol (1983) 130 (6): 2750–2756.
Suppression of ACTH-induced steroidogenesis by supernatants from LPS-treated peritoneal exudate macrophages.
J Immunol (1983) 130 (6): 2757–2762.
Generation of low m.w., C3-bearing immunoglobulin in human serum.
J Immunol (1983) 130 (6): 2775–2781.
Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies.
J Immunol (1983) 130 (6): 2794–2797.
Characterization of monoclonal antibodies that define rat T cell alloantigens.
J Immunol (1983) 130 (6): 2798–2803.
Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complement.
J Immunol (1983) 130 (6): 2809–2813.
Isolation and identification of the third component of complement of Japanese quails.
J Immunol (1983) 130 (6): 2814–2820.
Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement.
J Immunol (1983) 130 (6): 2821–2824.
Cell-bound C4b resists reduction by reducing agents: analysis by chain structure and by hemolytic activity.
J Immunol (1983) 130 (6): 2825–2830.
C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
J Immunol (1983) 130 (6): 2831–2836.
The biologic activity of mast cell granules. VI. The effect of vinblastine-induced neutropenia on rat cutaneous late phase reactions.
J Immunol (1983) 130 (6): 2837–2842.
Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors.
J Immunol (1983) 130 (6): 2843–2848.
Altered oxidative metabolism in selenium-deficient rat granulocytes.
J Immunol (1983) 130 (6): 2856–2860.
Stimulation of prostaglandin E and thromboxane synthesis in macrophages by purified C3b.
J Immunol (1983) 130 (6): 2861–2865.
A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
J Immunol (1983) 130 (6): 2866–2870.
Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate.
J Immunol (1983) 130 (6): 2871–2875.
IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.
J Immunol (1983) 130 (6): 2882–2885.
The malaria merozoite surface: a 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites.
J Immunol (1983) 130 (6): 2886–2890.
Lymphocyte function in experimental African trypanosomiasis. VI. Parasite-specific immunosuppression.
J Immunol (1983) 130 (6): 2896–2898.
Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
J Immunol (1983) 130 (6): 2899–2902.
Immunochemical structure of hepatitis B e antigen in the serum.
K Takahashi; A Machida; G Funatsu; M Nomura; S Usuda; S Aoyagi; K Tachibana; H Miyamoto; M Imai; T Nakamura; Y Miyakawa; M Mayumi
J Immunol (1983) 130 (6): 2903–2907.
Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes.
J Immunol (1983) 130 (6): 2908–2914.
A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
J Immunol (1983) 130 (6): 2937–2941.
Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
J Immunol (1983) 130 (6): 2942–2946.
Characterization of an antigen expressed by human natural killer cells.
J Immunol (1983) 130 (6): 2947–2951.
Characterization of cloned cytotoxic lymphocytes with NK-like activity.
J Immunol (1983) 130 (6): 2952–2959.
Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
J Immunol (1983) 130 (6): 2969–2973.
Alterations in lymphocyte homing patterns within mice exposed to ultraviolet radiation.
J Immunol (1983) 130 (6): 2974–2981.
Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
J Immunol (1983) 130 (6): 2982–2986.
Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
J Immunol (1983) 130 (6): 2987–2992.
ERRATA
Hepatobiliary transport of IgA immune complexes: molecular and cellular aspects
J Immunol (1983) 130 (6): 2995.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement